PharmaTimes April 15, 2024
Jen Brogan

Approximately 14% of the competition-submitted proposals were selected to receive funding

Nine researchers from University College London (UCL) have secured nearly £560m in funding from the European Research Council’s (ERC) Advanced Grants to advance researchers in fields including biochemistry, nanotechnologies and regenerative medicine.

Approximately 14% of the competition-submitted proposals were selected for funding, comprising 255 researchers, and could create over 2,000 new jobs.

Set up in 2007 by the EU, the ERC has been funding research via the Advanced Grant to universities and research centres across 19 EU member states and associated countries, including the UK, Germany and France.

The funding will be used for projects including the study of the roles of priority proteins in cellular quiescence and ageing,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Provider, Trends
AI-driven platform helps physicians diagnose untreated patients
Oh, Canada: U.S. Patients Don't Want Your Health Policies
Most Homeless People Have Mental Health Disorders
Hospital mergers are leading to higher prices. Will regulators step in?
UCSF Health breaks ground on $4.3B hospital

Share This Article